Lam Man-Kin: Confident Li Zili's Rich International Experience Can Lead Hong Kong's Reform of Drug Approval System

Newly appointed Director of Drug and Medical Device Regulation Li Zili said a cross-disciplinary scientific team centred on clinical review will be set up to build a drug regulatory authority with comprehensive capability, international trust and an independent strategic position. Director of Health Lam Man-Kin said he is confident that Li Zili's rich international experience and leadership can lead Hong Kong's reform of the drug approval system.